Nucleic Acids Research, 2001, Vol. 29, No. 23 4818-4825
© 2001 Oxford University Press
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells
Department of Cell Biology, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9039, USA
Telomerase is a reverse transcriptase that adds telomeric repeats to chromosomal ends. In most normal human somatic cells, telomerase is repressed and telomeres progressively shorten, leading to limited proliferative life-span. Telomerase reactivation is associated with cellular immortalization and is a frequent event during tumorigenesis. The telomerase ribonucleoprotein complex consists of two essential components, a catalytic protein subunit [human telomerase reverse transcriptase (hTERT)] and a template RNA (hTR). hTR is constitutively expressed, while hTERT is almost universally absent in telomerase-negative cells. Although repression of telomerase is transcriptional in telomerase-negative cells, post-transcriptional and assembly processes are likely to play important roles in regulating telomerase activity in those that are telomerase-positive. The telomerase transcript can also be alternatively spliced into a variety of non-functional forms. To establish the quantitative relationships between telomerase activity and its various components, we determined the numbers of molecules of hTR and hTERT mRNA, and the levels of alternatively spliced hTERT mRNA variants in normal, in vitro immortalized and cancer cell lines. We report here that there is surprisingly little variation in the proportion of alternatively spliced forms of hTERT in different cell lines. The only variation observed occurred when a change in splicing to non-functional forms appeared in response to conditions that repress telomerase activity in IDH4 cells. We also found that most telomerase-positive cell lines only contain a few molecules of potentially functional hTERT mRNA, and there is a correlation between telomerase activity and the levels of both hTR and hTERT +
+ß mRNA.
* To whom correspondence should be addressed. Tel: +1 214 648 2933; Fax: +1 214 648 8694; Email: woodring.wright{at}utsouthwestern.edu Correspondence may also be addressed to Jerry W. Shay. Tel: +1 214 648 3282; Fax: +1 214 648 8694; Email: jerry.shay{at}utsouthwestern.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Liu, K. Ishihara, T. Ichimura, N. Fujita, S. Hino, S. Tomita, S. Watanabe, N. Saitoh, T. Ito, and M. Nakao MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity J. Biol. Chem., February 20, 2009; 284(8): 5165 - 5174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chatagnon, S. Bougel, L. Perriaud, J. Lachuer, J. Benhattar, and R. Dante Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells Carcinogenesis, January 1, 2009; 30(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Tomlinson, E. B. Abreu, T. Ziegler, H. Ly, C. M. Counter, R. M. Terns, and M. P. Terns Telomerase Reverse Transcriptase Is Required for the Localization of Telomerase RNA to Cajal Bodies and Telomeres in Human Cancer Cells Mol. Biol. Cell, September 1, 2008; 19(9): 3793 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cao, L. I. Huschtscha, A. S. Nouwens, H. A. Pickett, A. A. Neumann, A. C-M. Chang, C. D. Toouli, T. M. Bryan, and R. R. Reddel Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels Cancer Res., May 1, 2008; 68(9): 3115 - 3123. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lou, X. Chen, M. Jalink, Q. Zhu, N. Ge, S. Zhao, X. Fang, Y. Fan, M. Bjorkholm, Z. Liu, et al. The Opposing Effect of Hypoxia-Inducible Factor-2{alpha} on Expression of Telomerase Reverse Transcriptase Mol. Cancer Res., August 1, 2007; 5(8): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Renaud, D. Loukinov, Z. Abdullaev, I. Guilleret, F. T. Bosman, V. Lobanenkov, and J. Benhattar Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene Nucleic Acids Res., February 28, 2007; 35(4): 1245 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mavrogiannou, A. Strati, A. Stathopoulou, E. G. Tsaroucha, L. Kaklamanis, and E. S. Lianidou Real-Time RT-PCR Quantification of Human Telomerase Reverse Transcriptase Splice Variants in Tumor Cell Lines and Non-Small Cell Lung Cancer Clin. Chem., January 1, 2007; 53(1): 53 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Mozdy and T. R. Cech Low abundance of telomerase in yeast: Implications for telomerase haploinsufficiency RNA, September 1, 2006; 12(9): 1721 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Renaud, D. Loukinov, F. T. Bosman, V. Lobanenkov, and J. Benhattar CTCF binds the proximal exonic region of hTERT and inhibits its transcription Nucleic Acids Res., December 2, 2005; 33(21): 6850 - 6860. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Faiola, X. Liu, S. Lo, S. Pan, K. Zhang, E. Lymar, A. Farina, and E. Martinez Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription Mol. Cell. Biol., December 1, 2005; 25(23): 10220 - 10234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takakura, S. Kyo, M. Inoue, W. E. Wright, and J. W. Shay Function of AP-1 in Transcription of the Telomerase Reverse Transcriptase Gene (TERT) in Human and Mouse Cells Mol. Cell. Biol., September 15, 2005; 25(18): 8037 - 8043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Jakupciak, P. E. Barker, W. Wang, S. Srivastava, and D. H. Atha Preparation and Characterization of Candidate Reference Materials for Telomerase Assays Clin. Chem., August 1, 2005; 51(8): 1443 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fan, Z. Liu, X. Fang, Z. Ge, N. Ge, Y. Jia, P. Sun, F. Lou, M. Bjorkholm, A. Gruber, et al. Differential Expression of Full-length Telomerase Reverse Transcriptase mRNA and Telomerase Activity between Normal and Malignant Renal Tissues Clin. Cancer Res., June 15, 2005; 11(12): 4331 - 4337. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Jakupciak, W. Wang, P. E. Barker, S. Srivastava, and D. H. Atha Analytical Validation of Telomerase Activity for Cancer Early Detection: TRAP/PCR-CE and hTERT mRNA Quantification Assay for High-Throughput Screening of Tumor Cells J. Mol. Diagn., August 1, 2004; 6(3): 157 - 165. [Abstract] [Full Text] |
||||
![]() |
D. Gomez, T. Lemarteleur, L. Lacroix, P. Mailliet, J.-L. Mergny, and J.-F. Riou Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing Nucleic Acids Res., January 16, 2004; 32(1): 371 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, R. L. Tomlinson, A. A. Lukowiak, R. M. Terns, and M. P. Terns Telomerase RNA Accumulates in Cajal Bodies in Human Cancer Cells Mol. Biol. Cell, January 1, 2004; 15(1): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gomez, N. Aouali, A. Londono-Vallejo, L. Lacroix, F. Megnin-Chanet, T. Lemarteleur, C. Douarre, K. Shin-ya, P. Mailliet, C. Trentesaux, et al. Resistance to the Short Term Antiproliferative Activity of the G-quadruplex Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration J. Biol. Chem., December 12, 2003; 278(50): 50554 - 50562. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ren, G. Gavory, H. Li, L. Ying, D. Klenerman, and S. Balasubramanian Identification of a new RNA{middle dot}RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation Nucleic Acids Res., November 15, 2003; 31(22): 6509 - 6515. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gomez, N. Aouali, A. Renaud, C. Douarre, K. Shin-ya, J. Tazi, S. Martinez, C. Trentesaux, H. Morjani, and J.-F. Riou Resistance to Senescence Induction and Telomere Shortening by a G-Quadruplex Ligand Inhibitor of Telomerase Cancer Res., October 1, 2003; 63(19): 6149 - 6153. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Guilleret, P. Yan, L. Guillou, R. Braunschweig, J.-M. Coindre, and J. Benhattar The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation Carcinogenesis, December 1, 2002; 23(12): 2025 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cui, S. Aslam, J. Fletcher, D. Wylie, M. Clinton, and A. J. Clark Stabilization of Telomere Length and Karyotypic Stability Are Directly Correlated with the Level of hTERT Gene Expression in Primary Fibroblasts J. Biol. Chem., October 4, 2002; 277(41): 38531 - 38539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF] |
||||










